Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives
There is an unmet need among the 1 in 5 infants with off-season RSV hospitalizations, which are associated with higher HCRU and costs. Current recommendations on RSV preventives offer limited protection for infants exposed to RSV outside the typical season.
Authors
- Sarah Pugh (ORCID: https://orcid.org/0000-0003-4347-2561)
- Jennifer Judy (ORCID: https://orcid.org/0000-0002-2246-9745)
- Alejandro Cané (ORCID: https://orcid.org/0000-0003-0778-6862)
- Jay Lin (ORCID: https://orcid.org/0000-0002-6376-8469)
- Amy Law
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Vaccines
- Published
- 2025-03-29
- DOI
- https://doi.org/10.3390/vaccines13040366
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Pfizer